Davey B. Daniel

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC.

C. Faivre-Finn, S. Senan, D. Raben, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.

J. Hainsworth, H. Burris, T. Mekhail, 2018, Lung cancer.

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

J. Naidoo, A. Villegas, C. Wadsworth, 2024, JTO clinical and research reports.